| Revealing macropinocytosis using nanoparticles N Means, CK Elechalawar, WR Chen, R Bhattacharya, P Mukherjee Molecular aspects of medicine 83, 100993, 2022 | 57 | 2022 |
| Blood Meal Source Characterization Using Illumina Sequencing in the Chagas Disease Vector Rhodnius pallescens (Hemiptera: Reduviidae) in Panamá TJ Kieran, NL Gottdenker, CP Varian, A Saldaña, N Means, D Owens, ... Journal of Medical Entomology 54 (6), 1786-1789, 2017 | 40 | 2017 |
| Enzymatic versus electrocatalytic oxidation of NADH at carbon‐nanotube electrodes modified with Glucose dehydrogenases: application in a bucky‐paper‐based glucose enzymatic … N Lalaoui, N Means, C Walgama, A Le Goff, M Holzinger, S Krishnan, ... ChemElectroChem 3 (12), 2058-2062, 2016 | 25 | 2016 |
| Edge-to-edge interaction between carbon nanotube–pyrene complexes and electrodes for biosensing and electrocatalytic applications C Walgama, N Means, NF Materer, S Krishnan Physical Chemistry Chemical Physics 17 (6), 4025-4028, 2015 | 17 | 2015 |
| Ubiquitin‐binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer X Xiong, G Rao, RV Roy, Y Zhang, N Means, A Dey, M Tsaliki, S Saha, ... The FASEB Journal 34 (9), 12024-12039, 2020 | 14 | 2020 |
| Dysregulated long non-coding RNA in Sjögren’s disease impacts both interferon and adaptive immune responses ML Joachims, B Khatri, C Li, KL Tessneer, JA Ice, AM Stolarczyk, ... RMD open 8 (2), e002672, 2022 | 13 | 2022 |
| Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer CK Elechalawar, SK Gulla, RV Roy, N Means, Y Zhang, S Asifa, ... Cancer Letters 589, 216810, 2024 | 4 | 2024 |
| Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation CK Elechalawar, G Rao, SK Gulla, MM Patel, A Frickenstein, N Means, ... ACS nano 17 (10), 9326-9337, 2023 | 4 | 2023 |
| Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis RV Roy, N Means, G Rao, S Asfa, V Madka, A Dey, Y Zhang, ... Cancer letters 578, 216455, 2023 | 3 | 2023 |
| Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation (vol 17, pg 9326, 2023) CK Elechalawar, G Rao, SK Gulla, MM Patel, A Frickenstein, N Means, ... ACS NANO, 2024 | | 2024 |
| Correction to “Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation” CK Elechalawar, G Rao, SK Gulla, MM Patel, A Frickenstein, N Means, ... ACS nano 18 (12), 9242-9242, 2024 | | 2024 |
| The Role of UBAP2 in the Pancreas and Pancreatic Disease Etiology NJ Means The University of Oklahoma Health Sciences Center, 2023 | | 2023 |
| POS0098 LINC01871, IMPLICATED IN SJÖGREN’S DISEASE PATHOGENESIS, IS REGULATED BY INTERFERON-G AND CALCINEURIN SIGNALING ML Joachims, B Khatri, C Li, KL Tessneer, J Ice, AM Stolarczyk, N Means, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 271-271, 2022 | | 2022 |
| CHAPTER IV: THE ROLE OF CYSTATHIONINE BETA SYNTHASE ON SP1 STABILIZATION AND LIPOGENESIS IN OVARIAN CANCER B Murphy, Y Zhang, N Means, G Rao, A Dey, SS Kollalad, R Bhattacharya, ... | | 2022 |
| FRI0270 Identification of novel dysregulated interferon-inducible non-coding rnas in sjÖgren’s syndrome N Means, JA Ice, I Adrianto, AM Stolarczyk, ML Joachims, A Rasmussen, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 674-674, 2018 | | 2018 |
| AB0153 Functional characterization of the sjögren’s syndrome-associated locus ddx6-cxcr5 S Khanam, ML Joachims, N Means, R Omdal, M Wahren-Herlenius, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1267-1267, 2018 | | 2018 |
| Identification of dysregulated Interferon-inducible non-coding RNAs in Sjogren's syndrome N Means, JA Ice, I Adrianto, AM Stolarczyk, M Joachims, A Rasmussen, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 36 (3), S308-S308, 2018 | | 2018 |
